Attorney General Letitia James of New York said on Thursday that she had filed a lawsuit against a for-profit stem cell clinic, Park Avenue Stem Cell, claiming it performed unproven, rogue procedures on patients with a wide range of medical conditions, from erectile dysfunction to heart disease

Quick Read

This briefing note from the Nuffield Council on Bioethics examines the ethical issues that can arise when patients and doctors wish to use experimental treatments

Quick Read

People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That’s not always a good idea

Quick Read

The FDA is powerless to stop them. The newly enacted right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate and dying patients

Quick Read

A key Republican lawmaker released a new version of so-called “right to try” legislation around midnight Friday, a pivotal next step in the effort to help dying patients get access to experimental therapies

Quick Read

Tomorrow, the UK Court of Appeal will review the controversial case of a British infant, Charlie Gard. Charlie’s parents are appealing a recent High Court decision that gave doctors permission to withdraw his life support. They have raised money for Charlie to travel to the US for an experimental medical treatment

Quick Read

How the Alberta government allowed a private foundation to offer an unproven ‘experimental’ health program to its citizens

Quick Read

Diagnosed with leukaemia in his early 40s, Chris Lihosit was saved by umbilical cord blood from three babies. But why is cord blood banking still the exception rather than the norm? Mosaic’s Bryn Nelson finds out

Quick Read